Metformin Hydrochloride Strides Pharma Uk (Metformin Hydrochloride)

Metformin Hydrochloride is a biguanide that acts on glucose metabolism to manage several hyperglycaemic conditions.

• Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial glucose levels.
• Prediabetes (impaired fasting glucose): helps reduce the risk of progression to overt diabetes.
• Gestational diabetes (when insulin is not suitable): assists in maintaining maternal blood glucose within target ranges.

• Metformin Hydrochloride reduces hepatic gluconeogenesis, decreases intestinal glucose absorption, and enhances peripheral insulin sensitivity by activating AMP‑activated protein kinase (AMPK). These actions collectively lower circulating glucose levels without stimulating insulin secretion.

Metformin Hydrochloride is associated with several adverse reactions that vary in frequency.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhoea: frequent loose stools, especially at treatment initiation.
• Abdominal discomfort: cramping or pain.
• Metallic taste: transient alteration of taste perception.
• Loss of appetite: reduced desire to eat.
• Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

• Lactic acidosis: rare but potentially fatal metabolic acidosis.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Hepatotoxicity: liver enzyme elevations or injury.
• Vitamin B12 deficiency: may develop with long‑term therapy.
• Hypoglycaemia: uncommon unless combined with other glucose‑lowering agents.
• Pancreatitis: rare inflammation of the pancreas.

Metformin Hydrochloride requires careful assessment before and during therapy.

• Renal function: evaluate eGFR before initiation and periodically thereafter.
• Hepatic impairment: use with caution in patients with liver disease.
• Lactic acidosis risk: avoid in conditions causing hypoxia or severe infection.
• Alcohol consumption: limit intake to reduce acidosis risk.
• Pregnancy and lactation: assess risk‑benefit; use only if clearly needed.
• Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, influencing its safety and efficacy.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute kidney injury.
• Cimetidine: can increase metformin plasma concentrations.
• Nucleoside reverse transcriptase inhibitors: raise risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask symptoms of hypoglycaemia.
• Diuretics: affect renal clearance of metformin.
• ACE inhibitors or ARBs: require monitoring of renal function and electrolytes.